申请人:Obsidian Therapeutics, Inc.
                            
                            
                                公开号:US20190192691A1
                            
                            
                                公开(公告)日:2019-06-27
                            
                            The present invention provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.